1
/
의
1
Elabscience
SKU(재고 관리 코드):PKSH033868
Recombinant Human CD40 Ligand/CD40L//TNFSF5 (N-mFc)
Recombinant Human CD40 Ligand/CD40L//TNFSF5 (N-mFc)
Introducing the Recombinant Human CD40 Ligand/CD40L/TNFSF5 (N-MFC), a cutting-edge product designed to revolutionize the field of immunology. This meticulously engineered recombinant protein offers unparalleled efficacy and reliability in facilitating immune responses and promoting cellular interactions.
Crafted with utmost precision, the Recombinant Human CD40 Ligand/CD40L/TNFSF5 (N-MFC) is a result of advanced biotechnological processes, ensuring its purity and potency. This product serves as a crucial tool for researchers and scientists seeking to unravel the intricate mechanisms of immune system regulation and harness its potential for therapeutic interventions.
The Recombinant Human CD40 Ligand/CD40L/TNFSF5 (N-MFC) exhibits exceptional binding affinity to its receptor, CD40, thereby initiating a cascade of signaling events that culminate in the activation of immune cells. This activation, in turn, triggers a myriad of immune responses, including the proliferation and differentiation of B cells, the enhancement of antigen presentation, and the modulation of cytokine production.
Furthermore, the Recombinant Human CD40 Ligand/CD40L/TNFSF5 (N-MFC) showcases remarkable stability and solubility, ensuring ease of handling and storage. Its consistent and reproducible performance guarantees reliable experimental outcomes, enabling researchers to delve deeper into the complexities of immune system regulation.
In summary, the Recombinant Human CD40 Ligand/CD40L/TNFSF5 (N-MFC) is an indispensable asset for immunological research, offering an unrivaled platform to investigate immune responses and their therapeutic implications. With its exceptional purity, binding affinity, and stability, this product is poised to revolutionize the field, empowering scientists to unlock the full potential of the immune system.
Crafted with utmost precision, the Recombinant Human CD40 Ligand/CD40L/TNFSF5 (N-MFC) is a result of advanced biotechnological processes, ensuring its purity and potency. This product serves as a crucial tool for researchers and scientists seeking to unravel the intricate mechanisms of immune system regulation and harness its potential for therapeutic interventions.
The Recombinant Human CD40 Ligand/CD40L/TNFSF5 (N-MFC) exhibits exceptional binding affinity to its receptor, CD40, thereby initiating a cascade of signaling events that culminate in the activation of immune cells. This activation, in turn, triggers a myriad of immune responses, including the proliferation and differentiation of B cells, the enhancement of antigen presentation, and the modulation of cytokine production.
Furthermore, the Recombinant Human CD40 Ligand/CD40L/TNFSF5 (N-MFC) showcases remarkable stability and solubility, ensuring ease of handling and storage. Its consistent and reproducible performance guarantees reliable experimental outcomes, enabling researchers to delve deeper into the complexities of immune system regulation.
In summary, the Recombinant Human CD40 Ligand/CD40L/TNFSF5 (N-MFC) is an indispensable asset for immunological research, offering an unrivaled platform to investigate immune responses and their therapeutic implications. With its exceptional purity, binding affinity, and stability, this product is poised to revolutionize the field, empowering scientists to unlock the full potential of the immune system.
Share
